Qualigen Therapeutics Inc.
13F holders, Q2 2024 (June 30)20holders
3new positions
2sold out
1famous investor
$0.17avg. 13F price*
At the end of Q2 2024, 20 institutions reported holding Qualigen Therapeutics Inc. in their 13F filings, unchanged from Q1 2024. 3 opened new positions and 2 sold out. The largest holders were UBS Group AG ($12K), Renaissance Technologies ($11K) and HRT Financial LP ($10K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Qualigen Therapeutics Inc.
- CUSIP
- 74754R202
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $18K |
| Exits | 2 | $22K |
All 13F filers, Q1 2024 → Q2 2024: 187,183 shares bought and 74,963 shares sold, net +112,220 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| UBS Group AG | 0.00% | New | 69,522 | $12K |
| Renaissance Technologies | 0.00% | Add +51.7% | 65,174 | $11K |
| HRT Financial LP | 0.00% | Add +392.2% | 61,540 | $10K |
| Geode Capital Management, LLC | 0.00% | Reduce -27.9% | 30,215 | $5K |
| BlackRock Inc. | 0.00% | No change | 25,607 | $4K |
| Virtu Financial LLC | 0.00% | Reduce -21.7% | 21,566 | $4K |
| XTX Topco Ltd | 0.00% | Add +113.1% | 23,129 | $4K |
| Vanguard Group Inc. | 0.00% | No change | 22,827 | $4K |
| Two Sigma Securities, LLC | 0.00% | New | 18,104 | $3K |
| Cresset Asset Management, LLC | 0.00% | New | 16,000 | $3K |
| Northern Trust Corp. | 0.00% | Reduce -0.2% | 11,899 | $2K |
| State Street Corp. | 0.00% | No change | 10,930 | $2K |
| HighMark Wealth Management LLC | 0.00% | No change | 8,009 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.5% | 6,058 | $1K |
| US Bancorp \de | 0.00% | No change | 824 | $142 |
| Group One Trading LLC | 0.00% | No change | 423 | $73 |
| JPMorgan Chase & Co. | 0.00% | Reduce -11.9% | 252 | $43 |
| Bank of America Corp. | 0.00% | Add +420.0% | 52 | $9 |
| Archer Investment Corp | 0.00% | No change | 16 | $3 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is QUALIGEN THERAPEUTICS INC's weight in each manager's 13F, not the share of Qualigen Therapeutics Inc. the manager owns.